PDEX Pro-Dex, Inc.
Healthcare$65.15+2.57%ClosedMarket Cap: $208.0M
As of 2026-05-26
Valuation
P/E (TTM)
14.32
PEG
0.21
P/B
4.50
P/S
2.72
EV/EBITDA
10.85
DCF Value
$133.34
FCF Yield
3.5%
Div Yield
0.0%
Margins & Returns
Gross Margin
27.8%
Operating Margin
14.5%
Net Margin
16.1%
ROE
29.1%
ROA
16.0%
ROIC
12.3%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q3 null | $19.9M | 30.7% | $3.1M | $3.9M | $— | — |
| Q2 null | $18.7M | 30.8% | $3.3M | $2.2M | $— | — |
| Q1 null | $18.5M | 29.0% | $3.1M | $4.7M | $— | — |
| Q4 null | $17.5M | 19.9% | $1.3M | $1.2M | $— | — |
| FY null | $66.6M | 29.3% | $10.7M | $9.0M | $— | — |
| Q3 null | $17.4M | 33.3% | $3.6M | $3.3M | $— | — |
| Q2 null | $16.8M | 30.2% | $2.7M | $2.0M | $— | — |
| Q1 null | $14.9M | 34.6% | $3.0M | $2.5M | $— | — |
| Q4 null | $15.0M | 27.2% | $2.4M | $1.6M | $— | — |
| FY null | $53.8M | 27.0% | $7.2M | $2.1M | $— | — |
| Q3 null | $14.3M | 28.0% | $2.2M | $655.0K | $— | — |
| Q2 2024 | $12.6M | 22.3% | $777.0K | $500.0K | $0.14 | — |